Literature DB >> 25876513

RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.

Núria Martín-Flores1, Joan Romaní-Aumedes1, Laura Rué2,3,4, Mercè Canal1, Phil Sanders2,3,4, Marco Straccia2,3,4, Nicholas D Allen5, Jordi Alberch2,3,4, Josep M Canals2,3,4, Esther Pérez-Navarro6,7,8, Cristina Malagelada9.   

Abstract

RTP801 expression is induced by cellular stress and has a pro-apoptotic function in non-proliferating differentiated cells such as neurons. In several neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease, elevated levels of RTP801 have been observed, which suggests a role for RTP801 in neuronal death. Neuronal death is also a pathological hallmark in Huntington's disease (HD), an inherited neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. Currently, the exact mechanisms underlying mutant huntingtin (mhtt)-induced toxicity are still unclear. Here, we investigated whether RTP801 is involved in (mhtt)-induced cell death. Ectopic exon-1 mhtt elevated RTP801 mRNA and protein levels in nerve growth factor (NGF)-differentiated PC12 cells and in rat primary cortical neurons. In neuronal PC12 cells, mhtt also contributed to RTP801 protein elevation by reducing its proteasomal degradation rate, in addition to promoting RTP801 gene expression. Interestingly, silencing RTP801 expression with short hairpin RNAs (shRNAs) blocked mhtt-induced cell death in NGF-differentiated PC12 cells. However, RTP801 protein levels were not altered in the striatum of Hdh(Q7/Q111) and R6/1 mice, two HD models that display motor deficits but not neuronal death. Importantly, RTP801 protein levels were elevated in both neural telencephalic progenitors differentiated from HD patient-derived induced pluripotent stem cells and in the putamen and cerebellum of human HD postmortem brains. Taken together, our results suggest that RTP801 is a novel downstream effector of mhtt-induced toxicity and that it may be relevant to the human disease.

Entities:  

Keywords:  Exon-1 mutant huntingtin; HdHQ7/Q111 mice; Neuron death; PC12 cells; Putamen; R6/1 mice; RTP801; Striatum

Mesh:

Substances:

Year:  2015        PMID: 25876513     DOI: 10.1007/s12035-015-9166-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  64 in total

1.  The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes.

Authors:  Kazuhiko Tagawa; Shigeki Marubuchi; Mei-Ling Qi; Yasushi Enokido; Takuya Tamura; Reina Inagaki; Miho Murata; Ichiro Kanazawa; Erich E Wanker; Hitoshi Okazawa
Journal:  J Neurosci       Date:  2007-01-24       Impact factor: 6.167

2.  RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801.

Authors:  Kay D Rittenhouse; Theodore R Johnson; Paolo Vicini; Brad Hirakawa; Dalia Kalabat; Amy H Yang; Wenhu Huang; Anthony S Basile
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-04       Impact factor: 4.799

3.  Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.

Authors:  Emily Mitchell Sontag; Gregor P Lotz; Namita Agrawal; Andrew Tran; Rebecca Aron; Guocheng Yang; Mihaela Necula; Alice Lau; Steven Finkbeiner; Charles Glabe; J Lawrence Marsh; Paul J Muchowski; Leslie M Thompson
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

4.  Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease.

Authors:  Miguel Díaz-Hernández; Jesús Torres-Peraza; Alejandro Salvatori-Abarca; María A Morán; Pilar Gómez-Ramos; Jordi Alberch; José J Lucas
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

5.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.

Authors:  Laura Rué; Rafael Alcalá-Vida; Graciela López-Soop; Jordi Creus-Muncunill; Jordi Alberch; Esther Pérez-Navarro
Journal:  Neuromolecular Med       Date:  2013-07-30       Impact factor: 3.843

7.  Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression.

Authors:  A Giralt; T Rodrigo; E D Martín; J R Gonzalez; M Milà; V Ceña; M Dierssen; J M Canals; J Alberch
Journal:  Neuroscience       Date:  2008-11-21       Impact factor: 3.590

8.  Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation.

Authors:  Shuichi Igarashi; Hokuto Morita; Kyla M Bennett; Yuji Tanaka; Simone Engelender; Matthew F Peters; Jillian K Cooper; Jonathan D Wood; Akira Sawa; Christopher A Ross
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

Review 9.  Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.

Authors:  S Sarkar; B Ravikumar; R A Floto; D C Rubinsztein
Journal:  Cell Death Differ       Date:  2008-07-18       Impact factor: 15.828

10.  Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.

Authors:  Ana Saavedra; Albert Giralt; Helena Arumí; Jordi Alberch; Esther Pérez-Navarro
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more
  7 in total

1.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

2.  Quinolinic acid induces cell apoptosis in PC12 cells through HIF-1-dependent RTP801 activation.

Authors:  Xiaojia Huang; Kaiyong Yang; Yi Zhang; Qiang Wang; Yongjin Li
Journal:  Metab Brain Dis       Date:  2016-01-06       Impact factor: 3.584

3.  RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer's disease.

Authors:  Albert Giralt; Cristina Malagelada; Leticia Pérez-Sisqués; Anna Sancho-Balsells; Júlia Solana-Balaguer; Genís Campoy-Campos; Marcel Vives-Isern; Ferran Soler-Palazón; Marta Anglada-Huguet; Miguel-Ángel López-Toledano; Eva-Maria Mandelkow; Jordi Alberch
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

Review 4.  Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.

Authors:  Adelaide Tousley; Kimberly B Kegel-Gleason
Journal:  J Huntingtons Dis       Date:  2016-06-28

5.  Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.

Authors:  Núria Martín-Flores; Leticia Pérez-Sisqués; Jordi Creus-Muncunill; Mercè Masana; Sílvia Ginés; Jordi Alberch; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Cell Death Dis       Date:  2020-07-30       Impact factor: 8.469

6.  RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington's Disease.

Authors:  Leticia Pérez-Sisqués; Júlia Solana-Balaguer; Genís Campoy-Campos; Núria Martín-Flores; Anna Sancho-Balsells; Marcel Vives-Isern; Ferran Soler-Palazón; Marta Garcia-Forn; Mercè Masana; Jordi Alberch; Esther Pérez-Navarro; Albert Giralt; Cristina Malagelada
Journal:  Biomolecules       Date:  2021-12-27

Review 7.  Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review.

Authors:  Ruth Monk; Bronwen Connor
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.